Becton, Dickinson and Co. (BDX)
Becton, Dickinson and Co. (BDX) is a global medical technology company specializing in the development and manufacturing of medical devices, supplies, and laboratory equipment. Founded in 1897, it is known for its innovations in healthcare including syringes, safety-engineered devices, and diagnostic products, serving healthcare institutions, life sciences, and general medical markets worldwide.
Dividend History
Investors can expect a dividend payout of $1.04 per share, scheduled to be distributed in 10 days on September 30, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 30, 2025 | $1.04 | 2025-09-08 | 2025-09-08 |
| June 30, 2025 | $1.04 | 2025-06-09 | 2025-06-09 |
| March 31, 2025 | $1.04 | 2025-03-10 | 2025-03-10 |
| December 31, 2024 | $1.04 | 2024-12-09 | 2024-12-09 |
| September 30, 2024 | $0.95 | 2024-09-09 | 2024-09-09 |
Dividends Summary
- Becton, Dickinson and Co. has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 82 days ago, on June 30, 2025
- The highest dividend payed out to investors during this period was $1.04 per share
- The average dividend paid during this period was $0.57 per share.
Company News
The Automated Microbiology Market is projected to grow from $7.87 billion in 2025 to $12.52 billion by 2030, with a 9.74% CAGR, driven by demand for efficient diagnostic solutions in healthcare and industrial sectors.
Becton Dickinson reported strong Q3 2025 financial results, with EPS of $3.68 beating estimates and revenue rising 10.4% to $5.51 billion. The company raised its full-year earnings guidance and showed robust performance across medical, life sciences, and interventional segments.
Universal Health Realty Income Trust offers a high 7.4% dividend yield, with a 40-year history of annual dividend increases. While attractive for income investors, it has slower dividend growth and potential conflicts of interest due to external management.
The Cooper Companies is well-positioned for growth, driven by strong prospects in its CooperVision and CooperSurgical business segments. However, unfavorable currency movements and rising costs continue to impact revenues and margins.
Dividend aristocrats like Becton, Dickinson and Polaris are trading at 52-week lows. Read why these stocks present potentially attractive buying opportunities.
